Efek pemberian rebusan kunyit dan gula merah pada pasien dengan tuberkulosis

The effect of turmeric and palm sugar decoction on patients with tuberculosis

https://doi.org/10.47539/jktp.v8i1.446

Authors

  • Ibrahim Wisapla Program Studi Sarjana Terapan Keperawatan, Jurusan Keperawatan, Politeknik Kesehatan Jayapura
  • Nurmah Rachman Program Studi Sarjana Terapan Keperawatan, Jurusan Keperawatan, Politeknik Kesehatan Jayapura,
  • Demianus Tafor Program Studi Sarjana Terapan Keperawatan, Jurusan Keperawatan, Politeknik Kesehatan

Keywords:

Tuberkulosis paru, kunyit, gula merah, terapi adjuvan, gejala klinis

Abstract

Tuberkulosis (TBC) tetap menjadi tantangan kesehatan global dengan tingginya angka kejadian dan kompleksitas pengobatan. Penelitian ini mengevaluasi efektivitas rebusan kunyit dan gula merah sebagai terapi adjuvan pada pasien TBC. Studi quasi-eksperimental dilakukan pada 20 pasien TBC yang menerima intervensi rebusan kunyit (5 gram) dan gula merah (10 gram) dua kali sehari selama 8 minggu, bersamaan dengan pengobatan OAT standar. Data dikumpulkan meliputi gejala klinis (batuk >2 minggu dan demam malam hari) serta berat badan. Analisis statistik menggunakan uji McNemar untuk gejala klinis dan paired t-test untuk berat badan. Sebanyak 60% responden berjenis kelamin laki-laki dengan distribusi usia merata (<35 dan ≥35 tahun masing-masing 50%). Terjadi penurunan signifikan proporsi pasien dengan batuk >2 minggu dari 100% menjadi 60% (p<0,001), namun perubahan pada demam malam hari tidak signifikan (75% menjadi 60%; p=0,581). Rerata berat badan meningkat signifikan dari 54,06±3,86 kg menjadi 56,82±0,79 kg (p<0,001). Rebusan kunyit dan gula merah menunjukkan efek signifikan dalam mengurangi gejala batuk dan meningkatkan berat badan pasien TBC. Temuan ini mendukung potensi penggunaan sebagai terapi adjuvan, meskipun diperlukan penelitian lebih lanjut dengan desain yang lebih ketat.

Tuberculosis (TB) remains a global health challenge due to its high incidence and the complexity of treatment. This study evaluated the effectiveness of a turmeric and palm sugar decoction as an adjuvant therapy for TB patients. A quasi-experimental study was conducted on 20 TB patients who received an intervention consisting of turmeric (5g) and palm sugar (10g) decoction administered twice daily for eight weeks, alongside standard anti-tuberculosis (OAT) treatment. Data collected included clinical symptoms (cough lasting more than two weeks and night-time fever) and body weight. Statistical analysis was performed using McNemar’s test for clinical symptoms and paired t-test for body weight. A total of 60% of respondents were male, with an even age distribution (<35 and ≥35 years, each comprising 50%). There was a significant reduction in the proportion of patients experiencing cough lasting more than two weeks, from 100% to 60% (p<0.001), although the change in night-time fever was not statistically significant (from 75% to 60%; p=0.581). The average body weight increased significantly from 54.06±3.86 kg to 56.82±0.79 kg (p<0.001). The turmeric and palm sugar decoction demonstrated a significant effect in reducing cough symptoms and improving body weight in TB patients. These findings support its potential as an adjuvant therapy, although further studies with more rigorous designs are warranted.

Downloads

Download data is not yet available.

References

Aggarwal, B. B., Gupta, S. C., & Sung, B. (2013). Curcumin: An orally bioavailable blocker of TNF and other pro-inflammatory biomarkers. British Journal of Pharmacology, 169(8), 1672-1692. DOI: https://doi.org/10.1111/bph.12131

Chen, X., et al. (2021). "Curcumin as a potential treatment for COVID-19". Phytotherapy Research, 35(3), 1167-1175. https://doi.org/10.1002/ptr.6895

Chen, Y., Liu, W., Li, W., Gao, C., & Zhou, H. (2019). Enhanced oral bioavailability of curcumin by a novel solid self-microemulsifying drug delivery system using octenyl succinic anhydride modified starch. International Journal of Biological Macromolecules, 131, 112-118.

Dai, J., et al. (2020). "Curcumin attenuates colistin-induced neurotoxicity in N2a cells via anti-inflammatory activity, suppression of oxidative stress, and apoptosis". Molecular Neurobiology, 57(10), 4213-4227. https://doi.org/10.1007/s12035-020-02022-0

Gupta, S. C., Patchva, S., & Aggarwal, B. B. (2013). Therapeutic roles of curcumin: Lessons learned from clinical trials. The AAPS Journal, 15(1), 195-218. DOI: https://doi.org/10.1208/s12248-012-9432-8

Hewlings, S.J., & Kalman, D.S. (2017). "Curcumin: A review of its effects on human health". Foods, 6(10), 92. https://doi.org/10.3390/foods6100092 DOI: https://doi.org/10.3390/foods6100092

Hou, X., Zhang, J., Ahmad, H., Zhang, H., Xu, Z., & Wang, T. (2018). Evaluation of antioxidant activities of ampelopsin and its protective effect in lipopolysaccharide-induced oxidative stress in mice. Food & Function, 9(4), 2200-2210.

Kim, J. H., Kim, Y. S., Song, G. G., & Park, J. J. (2012). Protective effect of curcumin on AAPH-induced oxidative stress and DNA fragmentation in human lung fibroblast cells. Journal of Medicinal Food, 15(9), 799-806.

Lachmandas, E., Beigier-Bompadre, M., Cheng, S. C., Kumar, V., van Laarhoven, A., Wang, X., ... & Netea, M. G. (2016). Rewiring cellular metabolism via the AKT/mTOR pathway contributes to host defence against Mycobacterium tuberculosis in human and murine cells. European Journal of Immunology, 46(11), 2574-2586. DOI: https://doi.org/10.1002/eji.201546259

Liu, C.H., et al. (2021). "Adjuvant therapies for tuberculosis: A host-directed approach". Frontiers in Immunology, 12, 740117. https://doi.org/10.3389/fimmu.2021.740117

Liu, C. H., Liu, H., & Ge, B. (2016). Innate immunity in tuberculosis: Host defense vs pathogen evasion. Cellular & Molecular Immunology, 14(12), 963-975. DOI: https://doi.org/10.1038/cmi.2017.88

Nahid, P., et al. (2019). "Treatment of drug-resistant tuberculosis: An official ATS/CDC/ERS/IDSA clinical practice guideline". American Journal of Respiratory and Critical Care Medicine, 200(10), e93-e142. https://doi.org/10.1164/rccm.201909-1874ST

Payyappallimana, U., & Venkatasubramanian, P. (2016). "Exploring Ayurvedic knowledge on food and health for addressing contemporary challenges". Frontiers in Public Health, 4, 57. https://doi.org/10.3389/fpubh.2016.00057 DOI: https://doi.org/10.3389/fpubh.2016.00057

Oh, S. W., Cha, J. Y., Jung, J. E., Chang, B. C., Kwon, H. J., Lee, B. R., & Kim, D. Y. (2011). Curcumin attenuates allergic airway inflammation and hyper-responsiveness in mice through NF-κB inhibition. Journal of Ethnopharmacology, 136(3), 414-421. DOI: https://doi.org/10.1016/j.jep.2010.07.026

Prasad, A. S. (2014). Zinc: An antioxidant and anti-inflammatory agent: Role of zinc in degenerative disorders of aging. Journal of Trace Elements in Medicine and Biology, 28(4), 364-371. DOI: https://doi.org/10.1016/j.jtemb.2014.07.019

Srivastava, S., et al. (2020). "Plant-based remedies for the management of tuberculosis: A comprehensive review of traditional knowledge and modern science". Journal of Ethnopharmacology, 258, 112895. https://doi.org/10.1016/j.jep.2020.112895 DOI: https://doi.org/10.1016/j.jep.2020.112895

Sun, J., Chen, F., Braun, C., Zhou, Y. Q., Rittner, H., Tian, Y. K., ... & Ye, D. W. (2018). Role of curcumin in the management of pathological pain. Phytomedicine, 48, 129-140. DOI: https://doi.org/10.1016/j.phymed.2018.04.045

Tsai, Y. M., Chien, C. F., Lin, L. C., & Tsai, T. H. (2011). Curcumin and its nano-formulation: The kinetics of tissue distribution and blood-brain barrier penetration. International Journal of Pharmaceutics, 416(1), 331-338. DOI: https://doi.org/10.1016/j.ijpharm.2011.06.030

WHO. (2022). "Global tuberculosis report 2022". Geneva: World Health Organization. https://www.who.int/publications/i/item/9789240061729

Yang, K. Y., Lin, L. C., Tseng, T. Y., Wang, S. C., & Tsai, T. H. (2017). Oral bioavailability of curcumin in rat and the herbal analysis from Curcuma longa by LC-MS/MS. Journal of Chromatography B, 853(1-2), 183-189. DOI: https://doi.org/10.1016/j.jchromb.2007.03.010

Zhang, Y., et al. (2020). "Curcumin attenuates pulmonary inflammation in lipopolysaccharide induced acute lung injury in neonatal rat model by activating peroxisome proliferator-activated receptor γ (PPARγ) pathway". Medical Science Monitor, 26, e922507. https://doi.org/10.12659/MSM.922507

Published

2025-06-25

How to Cite

Wisapla, I., Rachman, N., & Tafor, D. (2025). Efek pemberian rebusan kunyit dan gula merah pada pasien dengan tuberkulosis: The effect of turmeric and palm sugar decoction on patients with tuberculosis. JURNAL KEPERAWATAN TROPIS PAPUA, 8(1), 55–60. https://doi.org/10.47539/jktp.v8i1.446

Issue

Section

Article Research